share_log

Stifel Downgrades Editas Medicine to Hold, Lowers Price Target to $3

Stifel Downgrades Editas Medicine to Hold, Lowers Price Target to $3

斯蒂费尔将Editas Medicine评级下调至持有,目标价格下调至3美元
Benzinga ·  12/13 17:37  · 评级/大行评级

Stifel analyst Dae Gon Ha downgrades Editas Medicine (NASDAQ:EDIT) from Buy to Hold and lowers the price target from $11 to $3.

Stifel 分析师Dae Gon Ha将Editas Medicine(纳斯达克:EDIT)评级从买入下调至持有,并将目标价从11美元下调至3美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发